title: Key issues in inhibitor management in patients with haemophilia.
authors: Katherine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, United Kingdom.
authors: Keith
authors: K
authors: Gomez
authors: Department for Internal Medicine, Haemophilia Treatment Centre Vivantes, Klinikum im Friedrichshain, Berlin, Germany.
authors: Robert
authors: R
authors: Klamroth
authors: Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa.
authors: Johnny
authors: J
authors: Mahlangu
authors: "Angelo Bianchi Bonomi" Haemophilia and Thrombosis Centre, IRCCS Ca' Granda, Ospedale Maggiore Policlinico Foundation, Milan, Italy.
authors: Maria E
authors: ME
authors: Mancuso
authors: Haematology Department, Regional University Hospital "Carlos Haya", Málaga, Spain.
authors: María E
authors: ME
authors: Mingot
authors: IHTC Haemophilia Unit "Cláudio Luis Pizzigatti Corrêa", INCTS Blood Centre UNICAMP, University of Campinas, São Paulo, Brazil.
authors: Margareth Castro
authors: MC
authors: Ozelo
mesh_terms: D001779:Blood Coagulation Factors / Q000627:therapeutic use; D019468:Disease Management; D004306:Dose-Response Relationship, Immunologic; D005164:Factor IX / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D005169:Factor VIII / Q000235:genetics / Q000276:immunology* / Q000627:therapeutic use; D015942:Factor VIIa / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006467:Hemophilia A / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D002836:Hemophilia B / Q000235:genetics / Q000276:immunology* / Q000628:therapy; D006801:Humans; D007114:Immunization; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000276:immunology*; D015337:Multicenter Studies as Topic; D020125:Mutation, Missense; D010641:Phenotype; D011322:Primary Prevention; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D001779:Blood Coagulation Factors; D007518:Isoantibodies; D011994:Recombinant Proteins; C025667:prothrombin complex concentrates; D005169:Factor VIII; D005164:Factor IX; C103587:recombinant FVIIa; D015942:Factor VIIa